| |
Presentation |
Media |
Date |
|
AlzeCure medverkar på Erik Penser Banks temadag Life Science den 2 december, 2021
|
|
|
2 december, 2021
|
|
Follow us – Stay updated
|
|
|
22 november, 2021
|
|
AlzeCure Pharma – Redeye Life Science Day
|
|
|
11 november, 2021
|
|
AlzeCure update on the latest developments – Interview with CEO Martin Jönsson about the company, its projects developments in Alzheimer’s and pain, and future plans.
|
|
|
22 oktober, 2021
|
|
Alzecure presents at Healthcare Innovation Summit
|
|
|
7 oktober, 2021
|
|
Alzecure Pharma – Naventus Life Science Summit
|
|
|
29 september, 2021
|
|
Aktiespararna intervjuar VD Martin Jönsson – senaste kvartalsrapporten och framtidsutsikterna
|
|
|
20 september, 2021
|
|
AlzeCure Pharma – Aktiedagen Stockholm
|
|
|
7 september, 2021
|
|
Strategy Update on Alzheimer’s Disease & NeuroRestore
|
|
|
1 september, 2021
|
|
Alzheimer’s disease and the neurotrophins BDNF/NGF by Prof. Maria Eriksdotter M.D., PhD
|
|
|
1 september, 2021
|
|
Company Overview & Vision by Martin Jönsson CEO
|
|
|
1 september, 2021
|
|
NeuroRestore Background and evolution by Dr Pontus Forsell, PhD Head of Discovery & Research
|
|
|
1 september, 2021
|
|
Development plan for NeuroRestore ACD856 by Dr Johan Sandin, PhD Chief Scientific Officer
|
|
|
1 september, 2021
|
|
ACD856 – a novel positive allosteric modulator of Trk-receptors in clinical development for the treatment of Alzheimer’s disease; Scientific presentation at AAIC, July 26-30, 2021
|
|
|
29 juli, 2021
|
|
Om AlzeCures uppkomst och utveckling – Ett embryo som kan bli något stort – med Bengt Winblad, professor, senior vid Karolinska Institutet.
|
|
|
11 juni, 2021
|
|
Om Alzstatin och läkemedel vid Alzheimers sjukdom – med Bengt Winblad, professor, senior vid Karolinska Institutet.
|
|
|
11 juni, 2021
|
|
Om att drabbas av Alzheimers sjukdom, diagnostik, vården idag samt framtida behov – med Bengt Winblad, professor, senior vid Karolinska Institutet.
|
|
|
11 juni, 2021
|
|
Negativa allosteriska modulatorer av TrkA för behandling av smärta – Vetenskaplig presentation på smärtkonferensen IASP, juni 2021
|
|
|
11 juni, 2021
|
|
ACD440 – A Novel TRPV1 Antagonist for the Topical Treatment in Neuropathic Pain – Vetenskaplig presentation på smärtkonferensen IASP, juni 2021
|
|
|
9 juni, 2021
|
|
Alzecure: VD Martin Jönsson presenterar på Redeye Growth Day
|
|
|
7 juni, 2021
|
|
CEO Martin Jönsson after the company’s annual meeting
|
|
|
17 maj, 2021
|
|
TrkA- NAM – Project in osteoarthritis & other severe pain conditions by Head of Discovery & Research Pontus Forsell, 11 Maj, 2021
|
|
|
11 maj, 2021
|
|
ACD 440 – A novel VR1 antagonist for neuropathic pain by CSO Johan Sandin, 11 Maj, 2021
|
|
|
11 maj, 2021
|
|
Chronic Pain – a high unmet medical need by CMO Märta Segerdahl, 11 Maj, 2021
|
|
|
11 maj, 2021
|
|
Company overview and goals by CEO Martin Jönsson, 11 Maj, 2021
|
|
|
11 maj, 2021
|
|
Update on Progress in the Painless Platform, May 11, 2021
|
|
|
11 maj 2021
|
|
Alzecure: Interview with CEO Martin Jönsson and CSO Johan Sandin (video)
|
|
|
20 april 2021
|
|
Analysguiden: ”Smärtprojekt, en dold diamant”
|
|
|
10 mars 2021
|
|
Alzecure: Intervju med vd Martin Jönsson (video)
|
|
|
1 mars 2021
|
|
Analysguiden: Intervju med AlzeCure Pharma ”Vi har tagit stora kliv under 2020”
|
|
|
8 februari 2021
|
|
VD Martin Jönsson presentation, Aktiedagen Lund
|
|
|
27 januari 2021
|
|
Intervju med Johan Sandin (CSO) i Aktiespararnas analysguide
|
|
|
22 januari 2021
|
|
Improving Quality of Life for People with Neurodegenerative Diseases – Stockholm Researchers and Health Tech Companies
|
|
|
14 januari 2021
|
